Real Endpoints Payer Council (REPC)
The Real Endpoints Payer Council (REPC) is comprised of an elite and diverse group of payer and Integrated Delivery Network (IDN) executives. RE collaborates throughout the year to discuss key factors driving decision-making around drugs and diagnostics and their coverage. We do so through periodic discussions, webinars and an annual REPC Strategy Forum. REPC members use our various tools (including RxScorecard and Payer Impact) to help policy evaluations and formulary decisions and to anticipate and manage pharma spend. Finally, RE is currently working with several REPC members and manufacturers to design and mediate value-based deals.
For more information regarding REPC membership or to become a REPC
member click here.
National Business Director
Top 5 Pharma
Specialty Access Solutions, Top 5 Pharma
Director of Operations
Reimbursement and Patient Support Services, Top 20 Pharma
Chronis H. Manolis, RPh
Vice President, Pharmacy UPMC Health Plan
President , GlaxoSmithKline U.S.